Abstract
This chapter discusses FDG normal variant uptake in HIV patients and the role of FDG PET/CT in malignancies in HIV-infected patients, CNS manifestations of HIV, assessing fever of unknown origin in HIV patients, assessing response to highly active antiretroviral therapy, and assessing complications. FDG PET/CT has proven useful in the diagnosis, staging, and detection of metastasis and post treatment monitoring of several malignancies in HIV-infected patients. It also has the ability to make the important distinction between malignancy and infection in the evaluation of CNS lesions, leading to the initiation of the appropriate treatment and precluding the need for invasive biopsy. However, immunosuppression predisposes patients to a number of opportunistic infections, and therefore special care must be taken interpreting FDG PET/CT in HIV patients
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aoki Y, Tosato G (2004) Neoplastic conditions in the context of HIV-1 infection. Curr HIV Res 2:343–349
Bakheet SM, Powe J (1998) Benign causes of 18-FDG uptake on whole body imaging. Semin Nucl Med 28:352–358
Barker R, Kazmi F, Stebbing J et al (2009) FDG-PET/CT imaging in the management of HIV-associated multicentric Castleman’s disease. Eur J Nucl Med Mol Imaging 36:648–652
Bental M, Deutsch C (1993) Metabolic changes in activated T cells: an NMR study of human peripheral blood lymphocytes. Magn Reson Med 29:317–326
Bleeker-Rovers CP, van der Ven AJ, Zomer B et al (2004) F-18-fluorodeoxyglucose positron emission tomography for visualization of lipodystrophy in HIV-infected patients. AIDS 18:2430–2432
Blum KA, Lozanski G, Byrd JC (2004) Adult Burkitt leukemia and lymphoma. Blood 104:3009–3020
Boshoff C, Weiss R (2002) AIDS-related malignancies. Nat Rev Cancer 2:373–382
Bower M, Palmieri C, Dhillon T (2006) AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral therapy. Curr Opin Infect Dis 19:14–19
Brust D, Polis M, Davey R et al (2006) Fluorodeoxyglucose imaging in healthy subjects with HIV infection: impact of disease stage and therapy on pattern of nodal activation. AIDS 20:985–993
Carbone A, Gloghini A (2005) AIDS-related lymphomas: from pathogenesis to pathology. Br J Haematol 130:662–670
Castaigne C, Tondeur M, de Wit S, Hildebrand M, Clumeck N, Dusart M (2009) Clinical value of FDG-PET/CT for the diagnosis of human immunodeficiency virus-associated fever of unknown origin: a retrospective study. Nucl Med Commun 30:41–47
Chang Y, Cesarman E, Pessin MS et al (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science 266:1865–1869
Cotter SE, Grigsby PW, Siegel BA et al (2006) FDG-PET/CT in the evaluation of anal carcinoma. Int J Radiat Oncol Biol Phys 65:720–725
DeMario MD, Liebowitz DN (1998) Lymphomas in the immunocompromised patient. Semin Oncol 25:492–502
Dupin N, Diss TL, Kellam P et al (2000) HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood 95:1406–1412
Elder GA, Sever JL (1988) Neurologic disorders associated with AIDS retroviral infection. Rev Infect Dis 10:286–302
Euvrard S, Kanitakis J, Claudy A (2003) Skin cancers after organ transplantation. N Engl J Med 348:1681–1691
Fox CH, Tenner-Racz K, Racz P, Firpo A, Pizzo PA, Fauci AS (1991) Lymphoid germinal centers are reservoirs of human immunodeficiency virus type 1 RNA. J Infect Dis 164:1051–1057
French MA (2009) HIV/AIDS: immune reconstitution inflammatory syndrome: a reappraisal. Clin Infect Dis 48:101–107
Frisch M, Biggar RJ, Goedert JJ (2000) Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 92:1500–1510
Frisch M, Biggar RJ, Engels EA, Goedert JJ (2001) Association of cancer with AIDS-related immunosuppression in adults. JAMA 285:1736–1745
Gallagher B, Wang Z, Schymura MJ, Kahn A, Fordyce EJ (2001) Cancer incidence in New York state acquired immunodeficiency syndrome patients. Am J Epidemiol 154:544–556
Goshen E, Davidson T, Avigdor A, Zwas TS, Levy I (2008) PET/CT in the evaluation of lymphoma in patients with HIV-1 with suppressed viral loads. Clin Nucl Med 33:610–614
Grigsby PW, Siegel BA, Dehdashti F, Rader J, Zoberi I (2004) Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome. J Clin Oncol 22:2167–2171
Hall HI, Song R, Rhodes P et al (2008) Estimation of HIV incidence in the United States. JAMA 300:520–529
Hardy G, Worrell S, Hayes P et al (2004) Evidence of thymic reconstitution after highly active antiretroviral therapy in HIV-1 infection. HIV Med 5:67–73
Heald AE, Hoffman JM, Bartlett JA, Waskin HA (1996) Differentiation of central nervous system lesions in AIDS patients using positron emission tomography (PET). Int J STD AIDS 7:337–346
Heaton RK, Grant I, Butters N et al (1995) The HNRC 500—neuropsychology of HIV infection at different disease stages. J Int Neuropsychol Soc 1:231–251
Hillier JC, Shaw P, Miller RF et al (2004) Imaging features of multicentric Castleman’s disease in HIV infection. Clin Radiol 59:596–601
Hoffman JM, Waskin HA, Schifter T et al (1993) FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS. J Nucl Med 34:567–575
Iyengar S, Chin B, Margolick JB, Sabundayo BP, Schwartz DH (2003) Anatomical loci of HIV-associated immune activation and association with viraemia. Lancet 362:945–950
Jhanwar YS, Straus DJ (2006) The role of PET in lymphoma. J Nucl Med 47:1326–1334
Just PA, Fieschi C, Baillet G, Galicier L, Oksenhendler E, Moretti JL (2008) 18F-fluorodeoxyglucose positron emission tomography/computed tomography in AIDS-related Burkitt lymphoma. AIDS Patient Care STDS 22:695–700
Kedes DH, Operskalski E, Busch M, Kohn R, Flood J, Ganem D (1996) The seroepidemiology of human herpesvirus 8 (Kaposi’s sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med 2:918–924
Krown SE, Metroka C, Wernz JC (1989) Kaposi’s sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. J Clin Oncol 7:1201–1207
Kwan A, Seltzer M, Czernin J, Chou MJ, Kao CH (2001) Characterization of hilar lymph node by 18F-fluoro-2-deoxyglucose positron emission tomography in healthy subjects. Anticancer Res 21:701–706
Levy RM, Bredesen DE, Rosenblum ML, Davis RL (1989) Central nervous system disorders in AIDS. Immunol Ser 44:371–401
Liu Y (2009) Clinical significance of diffusely increased splenic uptake on FDG-PET. Nucl Med Commun 30:763–769
Lucignani G, Orunesu E, Cesari M et al (2009) FDG-PET imaging in HIV-infected subjects: relation with therapy and immunovirological variables. Eur J Nucl Med Mol Imaging 36:640–647
Manzardo C, Del Mar Ortega M, Sued O, Garcia F, Moreno A, Miro JM (2005) Central nervous system opportunistic infections in developed countries in the highly active antiretroviral therapy era. J Neurovirol 11(Suppl 3):72–82
Marjanovic S, Skog S, Heiden T, Tribukait B, Nelson BD (1991) Expression of glycolytic isoenzymes in activated human peripheral lymphocytes: cell cycle analysis using flow cytometry. Exp Cell Res 193:425–431
Mbulaiteye SM, Parkin DM, Rabkin CS (2003) Epidemiology of AIDS-related malignancies an international perspective. Hematol Oncol Clin North Am 17:673–696
Meintjes G, Lynen L (2008) Prevention and treatment of the immune reconstitution inflammatory syndrome. Curr Opin HIV AIDS 3:468–476
Nasti G, Tirelli U (2005) Highly active antiretroviral therapy in AIDS-associated Kaposi’s sarcoma (KS): implications for the design of therapeutic trials in patients with advanced symptomatic KS. J Clin Oncol 23:2433–2434
Nasti G, Talamini R, Antinori A et al (2003) AIDS-related Kaposi’s Sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS clinical trial group staging system in the Haart era—the Italian cooperative group on AIDS and tumors and the Italian cohort of patients naive from antiretrovirals. J Clin Oncol 21:2876–2882
Navia BA, Jordan BD, Price RW (1986) The AIDS dementia complex: I. Clinical features. Ann Neurol 19:517–524
Niu MT, Jermano JA, Reichelderfer P, Schnittman SM (1993) Summary of the National Institutes of Health workshop on primary human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses 9:913–924
O’Doherty MJ, Barrington SF, Campbell M, Lowe J, Bradbeer CS (1997) PET scanning and the human immunodeficiency virus-positive patient. J Nucl Med 38:1575–1583
Offiah CE, Turnbull IW (2006) The imaging appearances of intracranial CNS infections in adult HIV and AIDS patients. Clin Radiol 61:393–401
Oksenhendler E, Duarte M, Soulier J et al (1996) Multicentric Castleman’s disease in HIV infection: a clinical and pathological study of 20 patients. AIDS 10:61–67
Oksenhendler E, Boulanger E, Galicier L et al (2002) High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. Blood 99:2331–2336
Pantaleo G, Graziosi C, Butini L et al (1991) Lymphoid organs function as major reservoirs for human immunodeficiency virus. Proc Natl Acad Sci U S A 88:9838–9842
Pantaleo G, Graziosi C, Demarest JF et al (1994) Role of lymphoid organs in the pathogenesis of human immunodeficiency virus (HIV) infection. Immunol Rev 140:105–130
Pascal S, Resnick L, Barker WW et al (1991) Metabolic asymmetries in asymptomatic HIV-1 seropositive subjects: relationship to disease onset and MRI findings. J Nucl Med 32:1725–1729
Quinn TC (1996) Global burden of the HIV pandemic. Lancet 348:99–106
Rabkin CS, Yellin F (1994) Cancer incidence in a population with a high prevalence of infection with human immunodeficiency virus type 1. J Natl Cancer Inst 86:1711–1716
Rottenberg DA, Moeller JR, Strother SC et al (1987) The metabolic pathology of the AIDS dementia complex. Ann Neurol 22:700–706
Rottenberg DA, Sidtis JJ, Strother SC et al (1996) Abnormal cerebral glucose metabolism in HIV-1 seropositive subjects with and without dementia. J Nucl Med 37:1133–1141
Rubio A, Martinez-Moya M, Leal M et al (2002) Changes in thymus volume in adult HIV-infected patients under HAART: correlation with the T-cell repopulation. Clin Exp Immunol 130:121–126
Scharko AM, Perlman SB, Pyzalski RW, Graziano FM, Sosman J, Pauza CD (2003) Whole-body positron emission tomography in patients with HIV-1 infection. Lancet 362:959–961
Subhas N, Patel PV, Pannu HK, Jacene HA, Fishman EK, Wahl RL (2005) Imaging of pelvic malignancies with in-line FDG PET-CT: case examples and common pitfalls of FDG PET. Radiographics 25:1031–1043
Sugawara Y, Braun DK, Kison PV, Russo JE, Zasadny KR, Wahl RL (1998) Rapid detection of human infections with fluorine-18 fluorodeoxyglucose and positron emission tomography: preliminary results. Eur J Nucl Med 25:1238–1243
Tenner-Racz K, Racz P, Gluckman JC, Popovic M (1988) Cell-free HIV in lymph nodes of patients with AIDS and generalized lymphadenopathy. N Engl J Med 318:49–50
UNAIDS (2008) Report on the global AIDS epidemic. In: JUNPoHA (ed) UNAIDS ,Geneva
Villringer K, Jager H, Dichgans M et al (1995) Differential diagnosis of CNS lesions in AIDS patients by FDG-PET. J Comput Assist Tomogr 19:532–536
von Giesen HJ, Antke C, Hefter H, Wenserski F, Seitz RJ, Arendt G (2000) Potential time course of human immunodeficiency virus type 1-associated minor motor deficits: electrophysiologic and positron emission tomography findings. Arch Neurol 57:1601–1607
Wong TZ, Jones EL, Coleman RE (2004) Positron emission tomography with 2-deoxy-2-[(18)F]fluoro-d-glucose for evaluating local and distant disease in patients with cervical cancer. Mol Imaging Biol 6:55–62
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Subramaniam, R.M., Davison, J.M., Surasi, D.S., Jackson, T., Cooley, T. (2011). Patients with HIV. In: Peller, P., Subramaniam, R., Guermazi, A. (eds) PET-CT and PET-MRI in Oncology. Medical Radiology(). Springer, Berlin, Heidelberg. https://doi.org/10.1007/174_2011_459
Download citation
DOI: https://doi.org/10.1007/174_2011_459
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-01138-2
Online ISBN: 978-3-642-01139-9
eBook Packages: MedicineMedicine (R0)